Dormant neural stem cells in fruit flies activate to generate new brain cells
A new research study by Duke-NUS Medical School describes how dormant neural stem cells in fruit flies are activated and generate new neurons. The findings could potentially help people with brain injury or neuronal loss if similar mechanisms apply in humans.
Publishing in PLOS Biology, the research team, led by Associate Professor Wang Hongyan, deputy director of Duke-NUS’ Neuroscience and Behavioural Disorders Programme and lead author of the study, described the process and molecules involved in reactivating dormant neural stem cells in fruit flies (Drosophila), which can activate and generate new neurons. The ability of neural stem cells to switch from their dormant state and begin to proliferate is crucial in the brain. Until now, very little was known about how dormant neural stem cells become active.
Associate Professor Wang and colleagues investigated what factors are at play in developing Drosophila brains at the larval stage. They discovered that a protein complex called CRL4 is essential for the reactivation of neural stem cells, as it downregulates a pathway that normally keeps neural stem cells in the dormant state. They saw that CRL4 forms a protein complex with the tumour suppressor Warts, a core component of the pathway, and that CRL4 targets Warts for degradation to trigger reactivation.
The ability to awaken dormant neural stem cells could stimulate new neurons to compensate for brain injury or the neuronal loss seen in neurodegenerative diseases, such as Parkinson’s or Alzheimer’s. Future work is required to confirm that CRL4 and the pathway it regulates works in a similar manner in mammalian brains.
“Mutations of human Cullin4B, a core component of the CRL4 complex, are associated with mental retardation and cortical malformations,” said Associate Professor Wang. “Our work identifies the mechanisms behind CRL4 in fruit fly brain development and we plan to conduct further research to see if the same proteins are in play in mammals. Ultimately, our hope is that greater understanding and stimulation of these cells could eventually lead to therapeutic treatment of neurodevelopmental and neurodegenerative diseases.”
Source: Read Full Article